3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
3
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Ovarian Neoplasms
7
Fallopian Tube Neoplasms
6
Breast Neoplasms
6
Neoplasms
4
Sarcoma
3
Triple Negative Breast Neoplasms
2
Neoplasm Metastasis
2
Multi-centric Castleman's Disease
2
Lymphoma, B-Cell
2
Sarcoma, Kaposi
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Primary Effusion
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, AIDS-Related
1
Lymphoma
1
Lymphadenopathy
1
Lung Neoplasms
1
Leukemia-Lymphoma, Adult T-Cell
1
Kidney Neoplasms
1
Invasive Breast Cancer
1
Hereditary Sensory and Autonomic Neuropathies
1
HIV Infections
1
Glioma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Interventions
Cyclophosphamide
16
Vincristine
12
Prednisone
11
Methotrexate
11
Etoposide
9
Cytarabine
9
merphos
8
blinatumomab
8
venetoclax
7
prednylidene
7
pegaspargase
7
deltacortene
7
Specimen Handling
7
Mercaptopurine
7
Dexamethasone
7
azathiopurine
6
N,N-dicyclohexyl-isoborneol-10-sulfonamide
6
Doxorubicin
6
Calcium Dobesilate
6
dexamethasone acetate
5
dexamethasone 21-phosphate
5
auricularum
5
Spinal Puncture
5
Rituximab
5
Leucovorin
5
Biopsy
5
fludarabine phosphate
4
Stem Cell Transplantation
4
Methylprednisolone
4
Inotuzumab Ozogamicin
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Burkitt Lymphoma
×
liposomal doxorubicin
×
Clear all
NCT05270057
2025-10-09
LONCA
Medical College of Wisconsin
Phase 1
Active not recruiting
11 enrolled